MedTrace Logo

Prospective Study to Optimize Vancomycin Dosing in Children and Adults Using Computer Software

NCT01932034 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 263

Last updated 2018-02-20

No results posted yet for this study

Summary

We will compare the percentage of patients having therapeutic vancomycin serum concentrations after current standard dosing, after dosing with our software. We will also include therapeutic outcomes and costs in the analysis.

Conditions

Interventions

DEVICE

BestDose Computer Software

BestDose is made by the USC Laboratory of Applied Pharmacokinetics. It uses a multiple-model, Bayesian adaptive control algorithm to find the maximally precise dose that will achieve a user-specified target concentration or concentrations.

Sponsors & Collaborators

Principal Investigators

  • Michael Neely, MD · Children's Hospital Los Angeles

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2016-07-01
Completion
2016-07-04

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01932034 on ClinicalTrials.gov